- Home
- AGO vs AXSM Comparison
AGO vs AXSM Comparison
Compare AGO & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGO
- AXSM
- Stock Information
- Founded
- AGO 2003
- AXSM 2012
- Country
- AGO Bermuda
- AXSM United States
- Employees
- AGO N/A
- AXSM N/A
- Industry
- AGO Property-Casualty Insurers
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- AGO Finance
- AXSM Health Care
- Exchange
- AGO Nasdaq
- AXSM Nasdaq
- Market Cap
- AGO 4.2B
- AXSM 4.8B
- IPO Year
- AGO 2004
- AXSM 2015
- Fundamental
- Price
- AGO $83.27
- AXSM $104.46
- Analyst Decision
- AGO Buy
- AXSM Strong Buy
- Analyst Count
- AGO 3
- AXSM 15
- Target Price
- AGO $103.33
- AXSM $171.00
- AVG Volume (30 Days)
- AGO 475.4K
- AXSM 912.2K
- Earning Date
- AGO 05-06-2025
- AXSM 05-05-2025
- Dividend Yield
- AGO 1.63%
- AXSM N/A
- EPS Growth
- AGO N/A
- AXSM N/A
- EPS
- AGO 6.87
- AXSM N/A
- Revenue
- AGO $899,000,000.00
- AXSM $385,693,000.00
- Revenue This Year
- AGO N/A
- AXSM $63.85
- Revenue Next Year
- AGO N/A
- AXSM $63.93
- P/E Ratio
- AGO $12.12
- AXSM N/A
- Revenue Growth
- AGO N/A
- AXSM 42.53
- 52 Week Low
- AGO $72.57
- AXSM $64.11
- 52 Week High
- AGO $96.50
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- AGO 47.80
- AXSM 41.94
- Support Level
- AGO $78.60
- AXSM $86.99
- Resistance Level
- AGO $83.22
- AXSM $103.75
- Average True Range (ATR)
- AGO 2.91
- AXSM 5.84
- MACD
- AGO 0.17
- AXSM -0.01
- Stochastic Oscillator
- AGO 61.69
- AXSM 56.74
About AGO Assured Guaranty Ltd.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets, and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal and healthcare experience. The company is operating in two segments Insurance segment and the Asset Management segment. The majority of the revenue earned by the company from the Insurance segment.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.